Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.
作者信息
Rello Jordi, Tejada Sofia, Userovici Caroline, Arvaniti Kostoula, Pugin Jérôme, Waterer Grant
机构信息
Centro de Investigación Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain; Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain; Anaesthesiology and Critical Care Division, CHU Nîmes, University Montpellier-Nîmes, Nîmes, France.
Centro de Investigación Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain; Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain.
出版信息
Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.
Abstract
摘要
相似文献
1
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.2019冠状病毒病（COVID-19）：中国以外地区的重症监护视角
Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.
2
Respiratory support for patients with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染患者的呼吸支持
Lancet Respir Med. 2020 Apr;8(4):e18. doi: 10.1016/S2213-2600(20)30110-7. Epub 2020 Mar 5.
3
COVID-19, ECMO, and lymphopenia: a word of caution.新型冠状病毒肺炎、体外膜肺氧合与淋巴细胞减少：一则警示
Lancet Respir Med. 2020 Apr;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3. Epub 2020 Mar 13.
4
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
5
What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.皮肤科医生应对新型冠状病毒（SARS-CoV-2）的方法：一位来自中国的皮肤科医生的观点
J Eur Acad Dermatol Venereol. 2020 May;34(5):e211-e212. doi: 10.1111/jdv.16389.
6
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg.标准护理单元中 SARS-CoV-2 肺炎患者的深静脉血栓形成：探索冰山一角。
Thromb Res. 2020 Oct;194:216-219. doi: 10.1016/j.thromres.2020.08.008. Epub 2020 Aug 6.
7
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.在新冠疫情期间进行微创手术时SARS-CoV-2传播的风险
Eur Urol. 2020 Jul;78(1):e12-e13. doi: 10.1016/j.eururo.2020.04.015. Epub 2020 Apr 13.
8
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.在意大利 2019 冠状病毒病（COVID-19）传播期间的癌症护理：青年肿瘤学家的观点。
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2020-000759.
9
[SARS-CoV-2 and the scientific community].[严重急性呼吸综合征冠状病毒2与科学界]
G Ital Cardiol (Rome). 2020 May;21(5):317-320. doi: 10.1714/3343.33126.
10
TEMPORARY REMOVAL: Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection.临时迁移：新冠病毒感染疫情期间中国医护人员的死亡特征
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.030. Epub 2020 Apr 8.
引用本文的文献
1
Telemedicine in pulmonary rehabilitation - benefits of a telerehabilitation program in post-COVID-19 patients: a controlled quasi-experimental study.远程医疗在肺康复中的应用——新冠后患者远程康复计划的获益：一项对照类准实验研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167354. doi: 10.1177/17534666231167354.
2
How Should Anesthesiologists Face Coronavirus Disease 2019?麻醉医生应如何应对2019冠状病毒病？
Front Cardiovasc Med. 2022 May 27;9:890967. doi: 10.3389/fcvm.2022.890967. eCollection 2022.
3
[Extracorporeal membrane oxygenation in COVID-19].[新型冠状病毒肺炎中的体外膜肺氧合]
Rev Fac Cien Med Univ Nac Cordoba. 2022 Mar 7;79(1):65-68. doi: 10.31053/1853.0605.v79.n1.29337.
4
A Review of Mortality Risk Prediction Models in Smartphone Applications.智能手机应用程序中死亡率风险预测模型的研究综述
J Med Syst. 2021 Nov 4;45(12):107. doi: 10.1007/s10916-021-01776-x.
5
[Severe SARS-CoV-2 infection: Clinical assessment and biomechanical functional evaluation one month after hospital discharge].[严重新型冠状病毒2型感染：出院后1个月的临床评估和生物力学功能评价]
Rehabilitacion (Madr). 2022 Apr-Jun;56(2):142-149. doi: 10.1016/j.rh.2021.07.003. Epub 2021 Aug 5.
6
Indicators and prediction models for the severity of Covid-19.Covid-19 严重程度的预测指标和预测模型。
Int J Clin Pract. 2021 Oct;75(10):e14571. doi: 10.1111/ijcp.14571. Epub 2021 Jul 6.
7
Managing COVID-19 related distress in primary care: principles of assessment and management.管理初级保健中的 COVID-19 相关困扰：评估和管理原则。
BMC Fam Pract. 2021 Apr 14;22(1):73. doi: 10.1186/s12875-021-01399-8.
8
Unexplained elevation of erythrocyte sedimentation rate in a patient recovering from COVID-19: A case report.1例新冠康复患者红细胞沉降率不明原因升高：病例报告
World J Clin Cases. 2021 Feb 26;9(6):1394-1401. doi: 10.12998/wjcc.v9.i6.1394.
9
Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.COVID-19 患者中伴有和不伴有 2 型糖尿病的临床和血液学特征的差异。
J Diabetes Res. 2020 Dec 2;2020:1038585. doi: 10.1155/2020/1038585. eCollection 2020.
10
From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.从COVID-19的放射学表现到肺部发病机制：一项从实验台到病床旁的综述
Radiol Res Pract. 2020 Dec 4;2020:8825761. doi: 10.1155/2020/8825761. eCollection 2020.
本文引用的文献
1
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
2
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
3
Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.胸部CT对新型冠状病毒肺炎的敏感性：与逆转录聚合酶链反应的比较。
Radiology. 2020 Aug;296(2):E115-E117. doi: 10.1148/radiol.2020200432. Epub 2020 Feb 19.
4
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病（COVID-19）疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
5
Strengthening ICU health security for a coronavirus epidemic.加强重症监护病房针对冠状病毒疫情的卫生安全保障。
Intensive Crit Care Nurs. 2020 Apr;57:102812. doi: 10.1016/j.iccn.2020.102812. Epub 2020 Feb 7.
6
Critical care management of adults with community-acquired severe respiratory viral infection.成人社区获得性严重呼吸道病毒感染的重症监护管理。
Intensive Care Med. 2020 Feb;46(2):315-328. doi: 10.1007/s00134-020-05943-5. Epub 2020 Feb 10.
7
Situations Leading to Reduced Effectiveness of Current Hand Hygiene against Infectious Mucus from Influenza Virus-Infected Patients.导致当前手部卫生措施对流感病毒感染患者传染性黏液效果降低的情况。
mSphere. 2019 Sep 18;4(5):e00474-19. doi: 10.1128/mSphere.00474-19.
8
Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome.中东呼吸综合征危重症患者的无创通气。
Influenza Other Respir Viruses. 2019 Jul;13(4):382-390. doi: 10.1111/irv.12635. Epub 2019 Mar 18.
9
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
10
The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases.阿奇霉素治疗弥漫性泛细支气管炎患者的疗效：29 例回顾性研究。
J Thorac Dis. 2013 Oct;5(5):613-7. doi: 10.3978/j.issn.2072-1439.2013.09.01.
Zotero 插件